540 



IM MUNO-CATAL YSIS 



Phosphohexose-isomerase, 365, 370 

 Phosphoprotein, 37 

 Phosphorylase, 227-228, 365, 370, 

 377 

 adenylic acid, coenzyme of, 377 

 crystalline, 26 



phospho-enoZ-trans-, 368, 371 

 Phosphorylation, 365-372 



energy relationship in, 369 

 Pilocarpine, 419 



Plasma cells (plasmocytes, phagocytes) 

 antibody synthesis, as site of, 73- 



77 

 increase of, 74, 75 



during active immunity, 74, 75 

 parallel with hypoglobulinemia, 

 74 

 lymphocytes and, transition be- 

 tween, 74 

 myeloma, large number in, 76 

 reticulo-endothelial system and, 74 



originating from, 75 

 pentose nucleic acid in, 76 

 Plasma clot (see Fibrin, Clotting) 

 Plasmin, 264, 274 

 Plasminogen, 264, 274 

 Plasmopheresis, 54 

 Platinum, 12 

 Pneumococcal 



hemolysin, 319-324 

 antibody against, 319 

 clinical aspect, 324 

 destruction by trypsin, 319 

 inhibition by cholesterol, 319, 322 

 thiol group, relation to, 320 

 infection, 59, 61 

 Pneumococcus, 3 

 agglutinin, 191 

 amino acid oxidase, 375 

 antibody against, 8, 55, 74, 116, 

 123-125 

 fate of, when passively intro- 

 duced, 55-60 

 metabolism of, 57 

 destruction by H2O2, 28 



hyaluronidase, 234, 235, 238, 243 

 metabolism, effect of antiserum on, 



388-390 

 mucolytic activity of, 235 

 Polarization, 1 1 



Polypeptides (Peptides), 54-55, 87, 

 111, 115, 156, 161-163 

 p-aminobenzoic acid in, 55 

 anaphylaxis and, 434 

 Bacillus anthracis, capsular sub- 

 stance, 54, 114 

 Bacillus hrevis, 55 



d-glutamic acid composition of, 



54, 114 

 proteolytic enzymes, resistance to, 

 54 

 haptenic property of, 54, 115 

 low molecular weight, 54, 114- 

 116,439 

 pepsin inhibitor, 114, 160-162 

 trypsin inhibitor, 114, 162-163, 

 178-180, 439 

 Saccharotnyces cerevisiae, 54—55 

 subtilis groups, 54 

 serological specificity of, 114-116, 

 120 

 Polysaccharidases, 230 

 antibody against, 230 

 Polysaccharide(s) 

 as antigen, 143 

 antibody complex, action of lyso- 



zyme on, 211 

 antibody precipitate as antigen, 136 

 B. dysenteriae, 34 



antibody against, 34-35 

 Bacillus -palustris, 230 

 capsular, relation to virulence, 244— 



245 

 dextran, 228 

 globulins, 130-131 



as possible seat of specificity, 

 130-131 

 levulan, 228 

 mucopolysaccharides, 233-235 



